Most pest control businesses in Canada change hands at a multiple of their normalized earnings, typically EBITDA (earnings before interest, taxes, depreciation, and amortization), adjusted for owner add-backs. The multiple itself depends on your size, location, growth trajectory, and how much the business depends on you, the owner.
Pest control companies are valued heavily on recurring service revenue. Buyers pay more for a book of quarterly and monthly contracts, low customer churn, and licensed technicians who stay after a sale. One-off treatments, seasonal-only demand, and an owner who runs the routes personally pull offers down.
Pushes the number up
- Recurring quarterly and monthly service contracts
- Low customer churn and high renewal rates
- Licensed technicians who stay through a transition
- A diversified mix of residential and commercial accounts
Pulls the number down
- Mostly one-off treatments with little recurring base
- Seasonal-only demand with no year-round route density
- Owner runs the routes or sales personally
- Concentration in a few large commercial accounts
You put in your numbers. We show you two things.
Market data: Sector-specific transaction multiples based on aggregated business transaction reports. Updated quarterly.
Peer benchmarks: Estimates from verified owners in your sector and size range. See what similar businesses are worth, and compare your own expectations against market data and transaction multiples.
Takes about three minutes.
No pitch. No account required. Just your numbers in, and market context out.
Get My InsightsPest control businesses are valued as a multiple of normalized EBITDA (earnings with owner add-backs). Recurring contract revenue, churn, and owner dependence move the number more than almost anything else. Clariva shows the benchmark range for your size and province.
Higher for firms with a large recurring contract base and technicians who stay; lower for owner-run, one-off, or seasonal operations. Enter your numbers to see your range.
Yes. A book of quarterly and monthly contracts makes future cash flow predictable, and buyers reward that with a stronger multiple than one-time treatments.
No. The estimate is for benchmarking and context only, and does not replace a formal business valuation. For a transaction, work with an M&A advisor or a Chartered Business Valuator (CBV).
Run the numbers for another business:
Not financial advice. Clariva is a data aggregation and compilation tool. All ranges shown on this platform are derived from publicly available transaction data and anonymized user submissions, and are provided for informational and benchmarking purposes only. Nothing on this platform constitutes a formal business valuation, financial advice, or a recommendation to buy or sell. Consult a qualified M&A advisor, Chartered Business Valuator (CBV), or legal counsel before making any financial or transactional decisions. Individual data is never shared or sold. Anonymized, aggregated insights may be used for industry research. You can request deletion of your data at any time by emailing tanner@clariva.ca.